We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

HMPL-453

Advertisement

cGxPJobs Banner

HUTCHMED Reports Strong Phase II Fanregratinib Data in ICC

HONG KONG, SHANGHAI & FLORHAM PARK, N.J., June 25, 2026 HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) announced that pivotal Phase II registration...

By cGxPwire Editor
June 25, 2026

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

Ionis Wins FDA Approval for TRYNGOLZA in Severe Hypertriglyceridemia
June 25, 2026
02

Bio-Pharma

Revolution Medicines Presents RAS(ON) Data at ESMO 2026
June 25, 2026
03

.Clinical

HUTCHMED Reports Strong Phase II Fanregratinib Data in ICC
June 25, 2026
04

Bio-Pharma

C Ray Therapeutics Secures Key Radiopharmaceutical License
June 25, 2026
05

.Clinical Bio-Pharma

CalciMedica Secures $49M Financing to Advance PH Program
June 25, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website